Genetic Testing and Immunotherapy for Intracranial Inflammatory Myofibroblastic Tumor: A Case Report

References

• Silva W, Zavarez LB, Zanferrari FL, et al. Inflammatory myofibroblastic tumor: rare manifestation in face. J Craniofac Surg. 2017;28(8):e751–e2. doi:10.1097/SCS.0000000000003954
   PubMed Web of Science ®Google Scholar
• Barata F, Marques D, Figueiredo A. Rare and unpredictable inflammatory myofibroblastic tumor. Rev Port Cir Cardiotorac Vasc. 2020;27(2):79–80.
   PubMedGoogle Scholar
• Cottrell TR, Duong AT, Gocke CD, et al. Pd-l1 expression in inflammatory myofibroblastic tumors. Mod Pathol. 2018;31(7):1155–1163. doi:10.1038/s41379-018-0034-6
   PubMed Web of Science ®Google Scholar
• Lovly CM, Gupta A, Lipson D, et al. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. Cancer Discov. 2014;4(8):889–895. doi:10.1158/2159-8290.cd-14-0377
   PubMed Web of Science ®Google Scholar
• Ding Y, Yang HY, Zhang D, et al. Diagnosis and treatment of inflammatory myofibroblastoma in children and adolescents. Chin Med J. 2019;132(9):1110–1112. doi:10.1097/CM9.0000000000000176
   PubMed Web of Science ®Google Scholar
• Chuah YY, Tashi T, Shy CG, Shyu JS, Dong MJ, Hsueh EJ. Intracranial inflammatory myofibroblastic tumor with sarcomatous local recurrence. World Neurosurg. 2016;93(484):e1–e4. doi:10.1016/j.wneu.2016.07.060
   PubMed Web of Science ®Google Scholar
• Shao R, Zhang Z, Xu Z, et al. H3k36 methyltransferase nsd1 regulates chondrocyte differentiation for skeletal development and fracture repair. Bone Res. 2021;9(1):30. doi:10.1038/s41413-021-00148-y
   PubMed Web of Science ®Google Scholar
• Bonvini P, Rossi E, Zin A, et al. Case report: circulating tumor cells as a response biomarker in alk-positive metastatic inflammatory myofibroblastic tumor. Front Pediatr. 2021;9:652583. doi:10.3389/fped.2021.652583
   PubMed Web of Science ®Google Scholar
• Carcamo B, Bista R, Wilson H, Reddy P, Pacheco J. Rapid response to lorlatinib in a patient with tfg-ros1 fusion positive inflammatory myofibroblastic tumor of the chest wall metastatic to the brain and refractory to First and second generation ros1 inhibitors. J Pediatr Hematol Oncol. 2021;43(5):e718–e22. doi:10.1097/mph.0000000000002185
   PubMed Web of Science ®Google Scholar
• Wong HH, Bentley H, Bulusu VR, et al. Lorlatinib for the treatment of inflammatory myofibroblastic tumour with tpm4-alk fusion following failure of entrectinib. Anticancer Drugs. 2020;31(10):1106–1110. doi:10.1097/cad.0000000000000994
   PubMed Web of Science ®Google Scholar
• Hou TC, Wu PS, Huang WY, et al. Over expression of cdk4 and mdm2 in a patient with recurrent alk-negative mediastinal inflammatory myofibroblastic tumor: a case report. Medicine. 2020;99(12):e19577. doi:10.1097/md.0000000000019577
   PubMed Web of Science ®Google Scholar
• Liu Q, Wei J, Liu X, Wang J. Anaplastic lymphoma kinase-negative pulmonary inflammatory myofibroblastic tumor with multiple metastases and its treatment by apatinib: a case report. Medicine. 2019;98(52):e18414. doi:10.1097/md.0000000000018414
   PubMed Web of Science ®Google Scholar
• Shimodaira Y, Sugawara K, Fukuda S, et al. Aggressive inflammatory myofibroblastic tumor without anaplastic lymphoma kinase gene rearrangement in the rectum with liver metastasis. Intern Med. 2020;59(4):495–499. doi:10.2169/internalmedicine.3686-19
   PubMed Web of Science ®Google Scholar
• Na YS, Park SG. Inflammatory myofibroblastic tumor of the pleura with adjacent chest wall invasion and metastasis to the kidney: a case report. J Med Case Rep. 2018;12(1):253. doi:10.1186/s13256-018-1796-7
   PubMedGoogle Scholar
• Rodrigues C, Cabral D, Almodovar T, et al. Unusual behavior of a lung inflammatory myofibroblastic tumor: case report. Rev Port Cir Cardiotorac Vasc. 2017;24(3–4):140.
   PubMedGoogle Scholar
• Zhang J, Li Y, Lou L. Uterine metastases originating from a pulmonary inflammatory myofibroblastic tumor. J Cancer Res Ther. 2018;14(Supplement):S257–s9. doi:10.4103/0973-1482.172129
   PubMed Web of Science ®Google Scholar
• Yuan C, Ma MJ, Parker JV, Mekhail TM. Metastatic anaplastic lymphoma kinase-1 (alk-1)-rearranged inflammatory myofibroblastic sarcoma to the brain with leptomeningeal involvement: favorable response to serial alk inhibitors: a case report. Am J Case Rep. 2017;18:799–804. doi:10.12659/ajcr.903698
   PubMed Web of Science ®Google Scholar
• Zorinas A, Austys D, Janusauskas V, et al. Small intestinal inflammatory myofibroblastic metastasis in the left ventricle. Ann Thorac Surg. 2017;103(1):e31–e3. doi:10.1016/j.athoracsur.2016.05.099
   PubMed Web of Science ®Google Scholar
• Gaudichon J, Jeanne-Pasquier C, Deparis M, et al. Complete and repeated response of a metastatic alk-rearranged inflammatory myofibroblastic tumor to crizotinib in a teenage girl. J Pediatr Hematol Oncol. 2016;38(4):308–311. doi:10.1097/mph.0000000000000498
   PubMed Web of Science ®Google Scholar
• Sethi B, Pai T, Allam A, Epari S. Anaplastic lymphoma kinase-positive pulmonary inflammatory myofibroblastic tumor with sarcomatous morphology and distant metastases: an unusual histomorphology and behavior. Indian J Pathol Microbiol. 2015;58(4):509–512. doi:10.4103/0377-4929.168866
   PubMed Web of Science ®Google Scholar
• Kim S, Bakkum-Gamez JN, Okuno S, Kerr S, Dowdy SC. Abdominopelvic inflammatory myofibroblastic tumor that metastasized to the vertebrae and liver: a case report and review of the literature. Gynecol Oncol Rep. 2015;12:9–12. doi:10.1016/j.gore.2015.01.007
   PubMedGoogle Scholar
• Choi EJ, Jin GY, Chung MJ, Moon WS, Youn HJ. Primary inflammatory myofibroblastic tumors of the breast with metastasis: radiographic and histopathologic predictive factors. J Breast Cancer. 2015;18(2):200–205. doi:10.4048/jbc.2015.18.2.200
   PubMed Web of Science ®Google Scholar
• Sun L, Tu L, Wang X, et al. Management of rectal inflammatory myofibroblastic tumor recurrence. J Cancer Res Ther. 2014;10(2):425–427. doi:10.4103/0973-1482.136679
   PubMed Web of Science ®Google Scholar
• Kubo N, Harada T, Anai S, et al. Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor. Intern Med. 2012;51(17):2399–2401. doi:10.2169/internalmedicine.51.7599
   PubMed Web of Science ®Google Scholar
• Carillo C, Anile M, De Giacomo T, Venuta F. Bilateral simultaneous inflammatory myofibroblastic tumor of the lung with distant metastatic spread. Interact Cardiovasc Thorac Surg. 2011;13(2):246–247. doi:10.1510/icvts.2011.271932
   PubMed Web of Science ®Google Scholar
• Gao S, Li N, Gao S, et al. Neoadjuvant pd-1 inhibitor (sintilimab) in NSCLC. J Thorac Oncol. 2020;15(5):816–826. doi:10.1016/j.jtho.2020.01.017
   PubMed Web of Science ®Google Scholar
• Shi Y, Su H, Song Y, et al. Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (orient-1): a multicentre, single-arm, Phase 2 trial. Lancet Haematol. 2019;6(1):e12–e9. doi:10.1016/s2352-3026(18)30192-3
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang Z, Fang J, et al. Efficacy and safety of sintilimab plus pemetrexed and platinum as first-line treatment for locally advanced or metastatic nonsquamous NSCLC: a randomized, double-blind, Phase 3 study (Oncology program by innovent anti-pd-1-11). J Thorac Oncol. 2020;15(10):1636–1646. doi:10.1016/j.jtho.2020.07.014
   PubMed Web of Science ®Google Scholar
• Jiang H, Li N, Wang H, et al. Assessment of tmb, pd-l1, and lymphocyte to monocyte ratio as predictive potential in a phase ib study of sintilimab in patients with advanced solid tumors. Am J Cancer Res. 2021;11(9):4259–4276.
   PubMed Web of Science ®Google Scholar
• Wang J, Fei K, Jing H, et al. Durable blockade of pd-1 signaling links preclinical efficacy of sintilimab to its clinical benefit. MAbs. 2019;11(8):1443–1451. doi:10.1080/19420862.2019.1654303
   PubMed Web of Science ®Google Scholar
• Watanabe H, Uruma T, Tazaki G, et al. Remission of alk-negative primary pulmonary inflammatory myofibroblastic tumor on treatment with clarithromycin: a case report and review of the literature. Oncol Lett. 2016;11(3):1757–1761. doi:10.3892/ol.2016.4119
   PubMed Web of Science ®Google Scholar